ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,600.57
1.13%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Mind Medicine MindMed Inc (MNMD)

  7. Mind Medicine MindMed Inc (MNMD) 뉴스

MNMD

Mind Medicine MindMed (MNMD)

Mind Medicine MindMed Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MNMD
일자시간출처헤드라인심볼기업
2024/05/0421:00Business WireMindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New YorkNASDAQ:MNMDMind Medicine MindMed Inc
2024/05/0220:00Business WireMindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:MNMDMind Medicine MindMed Inc
2024/04/2520:00Business WireMindMed to Present at Upcoming May Medical ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
2024/04/0220:00Business WireMindMed to Present at Upcoming April Medical ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
2024/04/0206:00Business WireMindMed Announces Voluntary Delisting from Cboe CanadaNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/1121:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/1120:00Business WireMindMed to Participate in the Leerink Partners 2024 Global Biopharma ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0722:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0721:13Business WireMind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private PlacementNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0721:09Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0720:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0720:00Business WireMindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety DisorderNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0203:56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0123:00Business WireMindMed to Host Conference Call and Webcast to Discuss Data Update for MM120NASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0106:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0106:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0106:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
2024/03/0106:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
2024/02/2821:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MNMDMind Medicine MindMed Inc
2024/02/2821:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
2024/02/2821:05Business WireMindMed Reports 2023 Financial Results and Business UpdatesNASDAQ:MNMDMind Medicine MindMed Inc
2024/02/2221:00Business WireMindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business UpdateNASDAQ:MNMDMind Medicine MindMed Inc
2024/02/0721:00Business WireMindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
2024/01/0822:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
2024/01/0821:45Business WireMindMed Announces Business Update and Anticipated Milestones for 2024NASDAQ:MNMDMind Medicine MindMed Inc
2023/12/2706:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
2023/12/2706:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
2023/12/2706:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
2023/12/2706:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
2023/12/2706:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
 검색 관련기사 보기:NASDAQ:MNMD

최근 히스토리

CCOM
US500
US 500
NASDAQ
TSLA
Tesla
NASDAQ
QQQ
Invesco QQQ Trust Series 1
PM
XAUUSD
Gold vs US Dollar
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
COIN
SOLUSD
Solana
CCOM
US30
US 30
NYSE
MCD
McDonalds
FX
USDEUR
US Dollar vs Euro
USOTC
BASFY
BASF (QX)
NASDAQ
GOOGL
Alphabet
NYSE
CVX
Chevron
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유